Rochester,NY 7/10/2009 7:59:16 PM
TEVA - Teva to Present Financial Results of 2nd Quarter 2009 - Sourced WhisperFromWallStreet.com
Teva Pharmaceutical Industries
TEVA - Teva to Present Financial Results of 2nd Quarter 2009 - Sourced WhisperFromWallStreet.com
---
Teva Pharmaceutical Industries,TEVA
After Hours: 0.00 N/A (N/A) 8:00PM ET
COMPANY NEWS
Teva Pharmaceutical Industries Ltd. announced today that it will release its second quarter 2009 financial results on Tuesday, July 28, 2009. Teva will host a conference call and live webcast on the same day, at 8:30 a.m. ET to discuss its second quarter 2009 results and overall business environment. A Question & Answer session will follow this discussion. The earnings release will be available on Teva’s web site at www.tevapharm.com prior to the call.
COMPANY INFORMATION
Teva Pharmaceutical Industries Limited engages in the development, production, and sale of a range of generic and branded pharmaceuticals, biogenerics, and active pharmaceutical ingredients (APIs) worldwide. Its research and development efforts focus on therapies for the central nervous system (with emphasis on multiple sclerosis), autoimmune diseases, and oncology. The company?s principal products include Copaxone for multiple sclerosis; and Azilect for Parkinson?s disease. Teva Pharmaceutical also provides specialty pharmaceutical products, which include respiratory products based on its proprietary delivery systems, including Easi-Breathe, an advanced breath-activated inhaler; Spiromax/Airmax, a multidose dry powder inhaler; and Cyclohaler, a single dose dry powder device.
---
INVESTOR AWARENESS
If you're an investor and interested in knowing which stocks are getting ready to run, sign up for our free "members only" alerts at http://whisperfromwallstreet.com
---
The following is an excerpt only, please read our complete disclaimer at http://whisperfromwallstreet.com/disclaimer.php
WhisperfromWallStreet.com (WFWS) based upon information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by WFWS to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. WFWS is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.whisperfromwallstreet.com or mentioned herein. WFWS may have been compensated with shares or with cash from third party shareholders or the company on behalf of one or more of the companies mentioned in this opinion.
